Making nanoparticles protein-like
- PMID: 38578738
- PMCID: PMC11285234
- DOI: 10.2217/nnm-2024-0084
Making nanoparticles protein-like
Keywords: antibody; artificial protein; conformational engineering; nanoparticles; specific interaction.
Conflict of interest statement
The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
References
-
- Wilhelm S, Tavares AJ, Dai Det al. . Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1(5), 16014 (2016).
-
- Sun D, Zhou S, Gao W. What went wrong with anticancer nanomedicine design and how to make it right. ACS Nano 14, 12281–12290 (2020). - PubMed
-
- Yang S-T, Liu Y, Wang Y-W, Cao A. Biosafety and bioapplication of nanomaterials by designing protein–nanoparticle interactions. Small 9(9–10), 1635–1653 (2013). - PubMed
-
- Yang S-T, Wang H, Guo L, Gao Y, Liu Y, Cao A. Interaction of fullerenol with lysozyme investigated by experimental and computational approaches. Nanotechnology 19, 395101 (2008). - PubMed
-
- Luo L, Liu Y-Y, Gao Tet al. . Characterization of the specific interactions between nanoparticles and proteins at residue-resolution by alanine scanning mutagenesis. ACS Appl. Mater. Interfaces 12, 34514–34523 (2020). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources